Depending on the application, the term fermentation can have a number of meanings. In a physiological sense, fermentation refers to a process that produces energy by breaking down energy rich compounds under anaerobic conditions. In a biotechnological context, however, this term is used in a much broader sense; thus, fermentation describes a process in which micro-organisms that are cultured on a large-scale under aerobic or anaerobic conditions convert a substrate into a useful product.
GEA is your competent partner for the manufacture of individual or multi-stage fermentation systems for the cultivation of micro-organisms and human/animal cells and complete plants for the pharmaceutical industry. Whatever it is you want from your fermentation plant — to manufacture recombinant genetic products for therapeutic purposes (TPA, interferon, insulin, h-Factor VII) or growth hormones and enzymes, or for diagnostic purposes (monoclonal antibodies) — our wide range of plant concepts will provide the equipment you need to meet any requirements or conditions. We use the latest components and valve technologies to produce high-performance fermenters and skids.
In addition, we also supply apparatus and modules for the production and storage of media, product harvesting, the storage and distribution of highly purified media/clean steam and the formulation of APIs. Offering a complete service to meet your every requirement and specification, our experienced process engineers will work with you to develop innovative and efficient process technologies for your specific fermentation applications.
Avoid upfront investment and preserve capital. GEA Financial Services offer to you attractive conditions to lease your new GEA equipment. Cost occur over time while the machine is used.
Video support designed to provide remote assistance in real-time.
Stay in touch with GEA innovations and stories by signing up for news from GEA.Sign up
We are here to help! With just a few details we will be able to respond to your inquiry.Contact us